SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-074106
Filing Date
2019-12-19
Accepted
2019-12-19 09:19:46
Documents
4
Period of Report
2019-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1926556d1_8k.htm 8-K 23499
2 EXHIBIT 10.1 tm1926556d1_ex10-1.htm EX-10.1 250542
3 EXHIBIT 99.1 tm1926556d1_ex99-1.htm EX-99.1 15359
4 GRAPHIC tm1926556d1_ex10-1img001.jpg GRAPHIC 5323
  Complete submission text file 0001104659-19-074106.txt   298186
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 191294273
SIC: 2834 Pharmaceutical Preparations